Intellia Therapeutics (NTLA) Stock Highlights

13.12 | -7.15%

2024-11-21 03:10:29

Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. Its evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Statistics

Range Today

12.82 14.27

Volume Today 4.47M

Range 1 Year

13.54 34.87

Volume 1 Year 425.52M

Range 3 Year

13.54 130.33

Volume 3 Year 979.68M

Range 10 Year

9.18 202.73

Volume 10 Year 2.07B

Highlights

Market Capitalization 1.7B (small)

Floating Shares 100.3M

Current Price 13.12

Price To Earnings -2.82

Price To Revenue 22.77

Price To Book 1.48

Earnings Per Share -5.7

Payout Ratio 0%

Performance

Latest -7.15%

1 Month -37.73%

3 Months -43.81%

6 Months -49.94%

1 Year -54.08%

3 Years -89.87%

5 Years -12.88%

10 Years -40.36%

Benchmarks

Market Capitalization

59 / 368

Gross Profits

273 / 278

Total Revenue

119 / 300

Total Rank

163 / 368

Free Cashflow

349 / 352

Performance 5 years

119 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.